iimveliso

I-zinc picolinate (17949-65-4)

I-Zinc Picolinate yityuwa ye-ionic ye-zinc kunye ne-picolinic acid. Esi songezelelo sinokubonelela ngomzimba ngezimbiwa, izinc. Esi songezelelo sinama-20% ezinc zinc ngokobunzima, oko kuthetha ukuba i-100 milligrams ye-zinc picolinate iya kuvelisa i-20 milligrams ye-zinc.

I-Zinc isebenza njenge-cofactor yee-enzymes ezininzi, kubandakanya ukuhlanganiswa kweprotein, ukuveliswa kwe-insulin kunye nokukhula kwengqondo. Ngaphandle kokubaluleka kwale minerali, imizimba yethu ayinakugcina i-Zinc egqithisileyo njengoko isenza ngokwendalo nezinye iiminerali kunye neevithamini. I-Zinc Picolinate yifom ye-asidi yeZinc umzimba womntu onokuyifumana ngokulula kunezinye iintlobo zeZinc.

Umgubo wobulumko unamandla okuvelisa nokubonelela ngobuninzi. Yonke imveliso phantsi kwemeko ye-cGMP kunye nenkqubo engqongqo yokulawula umgangatho, onke amaxwebhu okuvavanya kunye nesampuli ekhoyo.

Cela I Quote

Udidi: nezongezo

IZinc picolinate Ulwazi lweeChemical Base

igama	IZinc picolinate
CAS	17949-65-4
Ukungcola	98%
Igama leKhemikhali	IZinc picolinate
Iintetho ezifanayo	IZINC PICOLINATE; I-Picolinic acid zinc; ZINCPICOLINATE, umgubo; IZINTO ZE-PICOLINIC ACID ZINC SALT; I-zinc 2-pyridinecarboxylate; zinc, pyridine-2-carboxylate; IZINC PICOLINATE CAS 17949-65-4; I-zinc zinc i-ISO 9001: 2015 FINYELELA; Zinc Picolinate, 200-400 enemingxuma, Powder; I-Zinc, i-bis (2-pyridinecarboxylato-.kappa.N1, .kappa.O2) -, (T-4) -
I-Molecular Formula	I-C12H8N2O4Zn
Isisindo somzimba	309.58
Indawo yeBoling	292.5ºC kwi-760 mmHg
InChI Key	I-NHVUUBRKFZWXRN-UHFFFAOYSA-L
imo	solid
Kubonakala	Powder
Ubomi obulicla	/
Umzimba	I-Soluble emanzini
yoGcino Imeko	Gcina kwi-RT.
isicelo	Isetyenziswa njengesongezelelo sokutya okunesondlo njengomthombo we-zinc kunye ne-aspartic acid.
UXwebhu loVavanyo	iyafumaneka

I-Zinc picolinate powder 17949-65-4 Inkcazelo ngokubanzi

I-Zinc Picolinate sisongezo sokutya se-zinc esine-zinc ityuwa ye-picolinic acid, enokusetyenziselwa ukuthintela okanye ukunyanga ukusilela kwe-zinc, kunye nomsebenzi we-immunomodulatory. Emva kolawulo, i-zinc picolinate yongeza i-zinc. Njengento ebalulekileyo yokulandelela, i-zinc ibaluleke kakhulu kwiinkqubo ezininzi zebhayoloji. Idlala indima ebalulekileyo ekusebenzeni ngendlela efanelekileyo kwamajoni omzimba angaphakathi kunye nolungelelwaniso. I-Zinc inqanda ukuveliswa kwabalamli abanomdla wokuthintela kunye nokuthintela ukudumba. Isebenza njenge-antioxidant, ithintela umonakalo we-oxidative kwaye ikhusela iiseli kumonakalo we-DNA. I-Zinc iyadingeka kwimisebenzi ye-enzyme eyimfuneko ukwahlulwa kweseli, ukukhula kweseli, kunye nokuphilisa inxeba.

I-Zinc picolinate powder 17949-65-4 isicelo

Isiyobisi, ukongezwa kwendlela yokutya, amayeza ahambelana noko
Ukutya okongezayo, kubandakanya iziqholo, izicatshulwa, imibala, iincasa, njl njl. Kongezwe ukutya okusetyenziswa ngabantu
Ukhathalelo lomntu, iimveliso zokhathalelo lomntu, kubandakanya nezithambiso, ishampu, iziqholo, iisepha, into yokuthambisa, izinto zokuthambisa, njl.
Ukunyamekelwa, izithambiso, ukuthintelwa iYurophu, iikhemikhali kuluhlu luxhomekeke kuthintelo losetyenziso (okt ezinye izinto zivunyelwe, kodwa ukusetyenziswa kunqunyelwe) eYurophu

I-Zinc picolinate powder 17949-65-4 Uphando ngakumbi

I-Zinc picolinate yityuwa ye-zinc ye-picolinic acid. Iyafumaneka njengezongezelelo zokutya ze-OTC njengomthombo we-zinc ukunyanga nokukhusela ukusilela kwe-zinc. Ukufakwa kwe-zinc emva kolawulo lomlomo lwe-zinc picolinate kubonisiwe kuyasebenza.

isingqiniso

[1] Ukuqonda okutsha kwi-tryptophan kunye nemetabolites yayo kulawulo lweethambo metabolism.Michalowska M1, Znorko B2, Kaminski T1, Oksztulska-Kolanek E2, Pawlak D3. J iPhysiol Pharmacol. NgoDisemba ka-2015; 66 (6): 779-91.

[2] I-Barrie SA, i-Wright JV, i-Pizzorno JE, i-Kutter E, i-PC ye-Barron: Ukuthelekiswa kwe-zinc picolinate, i-zinc citrate kunye ne-zinc gluconate ebantwini. Izenzo zeearhente. Ngo-1987 ngoJuni; 21 (1-2): 223-8.

[3] Uvavanyo lwe-anticonvulsant potency ye-benzylamide derivatives ezahlukeneyo kwimodeli yokubamba ye-electroshock-induction. Świąder MJ1, Paruszewski R2, Łuszczki JJ3. IPhemacol Rep. 2016 Epreli; 68 (2): 259-62.